Frontotemporal Dementia Clinical Trials 2022

Browse 45 Frontotemporal Dementia Medical Studies Across 45 Cities

3 Phase 3 Trial · 115 Frontotemporal Dementia Clinics

Reviewed by Michael Gill, B. Sc.
25 Frontotemporal Dementia Clinical Trials Near Me
Rochester, MN
Madison, WI
Philadelphia, PA
New York, NY
More Trial Locations
An interactive map to display trial locations for Mayo Clinic Rochester, University of Wisconsin-Madison, Drexel University, Hospital for Special Surgery, and 68 more locations.
Most Popular References for Frontotemporal Dementia Clinical Trials
Frequency
Citation
2
Weiss JN, Levy S. Neurologic Stem Cell Treatment Study (NEST) using bone marrow derived stem cells for the treatment of neurological disorders and injuries: study protocol for a nonrandomized efficacy trial. Clin Trials Degener Dis. 2016 [cited 2019 Jun 18];1:176-80.
Top Hospitals for Frontotemporal Dementia Clinical Trials
Location
Active Frontotemporal Dementia Clinical Trials
All Time Trials for Frontotemporal Dementia
First Recorded Frontotemporal Dementia Trial
Trials
University of Pennsylvania, Philadelphia, Pennsylvania
7
23
2003
Sunnybrook Health Sciences Centre, Toronto, Ontario
3
5
2006
Top Treatments for Frontotemporal Dementia Clinical Trials
Treatment Name
Active Frontotemporal Dementia Clinical Trials
All Time Trials for Frontotemporal Dementia
First Recorded Frontotemporal Dementia Trial
Trials
Brain Health Community Registry Recruitment
1
1
2022
Immediate treatment group with Low-Intensity Prompts
1
1
2021
Top Cities for Frontotemporal Dementia Clinical Trials
City
Active Frontotemporal Dementia Clinical Trials
Top Active Site for Frontotemporal Dementia Clinical Trials
Trial List
San Francisco, California
9
University of California San Francisco
Phase 3 Frontotemporal Dementia Clinical Trials
Senior Friendly Frontotemporal Dementia Clinical Trials

About The Author

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 24th, 2021

Last Reviewed: August 28th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.